Abstract
Liquid biopsy is an extremely powerful tool in cancer patients with several potential applications that range from early cancer detection/cancer interception to real-time monitoring during anticancer therapies and tumor genotyping in advanced disease. Over the last few years great attention has been focused on early cancer detection, using different methodological approaches and liquid biopsy sources, including circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), metabolomics, and micro-RNAs.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
